Home -> Law Blog Directory -> Personal Injury Law Blogs -> LaBovick Injury Law Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: LaBovick Injury Law BlogVytorin Study comes under dispute
By Brian F. LaBovick, Esq.
There seems to be a dispute between two studies on risks involving Vytorin. In recent trials, data provided to the Food and Drug Administration on Thursday showed no increased risk of cancer.
However, a recently published study called Seas, disputes these findings and found an increased risk of cancer and deaths from cancer in patients taking Vytorin, compared with those given a placebo.
According to a WSJ article, the new Seas study, released in July, has surprised investors and the medical community.
Click here to read more on this Vytorin Study dispute from the Wallstreet Journal. (Note: Subscription required)
Full post as published by LaBovick Injury Law Blog on August 22, 2008 (boomark / email).
Vytorin
alleged risk of heart attack and liver damage.
Merck, Schering
Settle Vytorin Zetia Class Action
Procrit
Associated with Death in Stroke Study
Xigris
Study Prompts FDA Safety Review
BPA
New Study Shows Link to Diabetes and Heart Disease
Vytorin Marketing
alleged false claims in marketing campaign.

Vytorin Study Results on Potential Cancer Link to Be Released Next Week
Study Shows Cancer Link To Vytorin
Cardiologists Question Continued Use of Vytorin and Zetia
Study of Popular New Cholesterol Drug Shows its Effects are Limited
Vytorin Makers in Marketing Mess
Warning to Vytorin Users: It May Cause Cancer









